News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,567 Results
Type
Article (39054)
Company Profile (279)
Press Release (646234)
Section
Business (203865)
Career Advice (1990)
Deals (35367)
Drug Delivery (85)
Drug Development (80808)
Employer Resources (168)
FDA (16087)
Job Trends (14804)
News (344559)
Policy (32440)
Tag
Academia (2530)
Alliances (49085)
Alzheimer's disease (1228)
Approvals (16019)
Artificial intelligence (130)
Bankruptcy (352)
Best Places to Work (11534)
Biotechnology (200)
Breast cancer (120)
Cancer (1081)
Cardiovascular disease (97)
Career advice (1660)
Cell therapy (232)
Clinical research (64245)
Collaboration (386)
Compensation (197)
COVID-19 (2530)
C-suite (94)
Data (1119)
Diabetes (152)
Diagnostics (6138)
Earnings (84817)
Employer resources (146)
Events (109464)
Executive appointments (308)
FDA (16620)
Funding (348)
Gene therapy (176)
GLP-1 (575)
Government (4324)
Healthcare (18668)
Infectious disease (2614)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16296)
Job creations (3623)
Job search strategy (1417)
Layoffs (412)
Legal (7853)
Lung cancer (170)
Manufacturing (176)
Medical device (13174)
Medtech (13179)
Mergers & acquisitions (19143)
Metabolic disorders (401)
Neuroscience (1503)
NextGen Class of 2024 (6499)
Non-profit (4464)
Northern California (1475)
Obesity (231)
Opinion (179)
Patents (101)
People (56267)
Phase I (19951)
Phase II (28303)
Phase III (21099)
Pipeline (454)
Postmarket research (2553)
Preclinical (8489)
Radiopharmaceuticals (235)
Rare diseases (218)
Real estate (5890)
Regulatory (21521)
Research institute (2308)
Resumes & cover letters (349)
Southern California (1298)
Startups (3563)
United States (13419)
Vaccines (548)
Weight loss (167)
Date
Today (136)
Last 7 days (834)
Last 30 days (3780)
Last 365 days (35610)
2024 (32639)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46543)
2018 (35021)
2017 (32112)
2016 (31480)
2015 (37552)
2014 (31321)
2013 (26345)
2012 (28571)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (192)
Asia (37122)
Australia (6076)
California (3310)
Canada (1286)
China (247)
Colorado (144)
Connecticut (152)
Europe (79497)
Florida (457)
Georgia (116)
Illinois (340)
Indiana (196)
Kansas (96)
Maryland (575)
Massachusetts (2599)
Michigan (157)
Minnesota (272)
New Jersey (950)
New York (954)
North Carolina (698)
Northern California (1475)
Ohio (138)
Pennsylvania (842)
South America (1091)
Southern California (1298)
Texas (461)
Utah (90)
Washington State (358)
685,567 Results for "progenity inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”)(Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it has entered into a definitive agreement with ProGen Co., Ltd.
June 24, 2024
·
7 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Business
Progenity to Report First Quarter Financial Results and Provide Corporate Update as Biora Therapeutics, Inc.
Progenity, Inc. (Nasdaq: PROG) today announced that it will report first quarter ended March 31, 2022 financial results on Tuesday, May 10, 2022 after the close of financial markets.
May 3, 2022
·
1 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Boston Scientific Closes Acquisition of Axonics, Inc.
November 15, 2024
·
5 min read
Press Releases
Versant Ventures Unveils Pep2Tango Therapeutics Inc.
November 21, 2024
·
4 min read
Biotech Beach
Progenity to Become Biora Therapeutics as it Completes Transformation
Progenity, Inc. announced that it will change its name to Biora Therapeutics, Inc. during the second quarter of 2022, to better reflect the company’s focus on developing its pipeline for targeted and systemic oral delivery of biotherapeutics.
April 12, 2022
·
1 min read
Press Releases
Progyny, Inc. to Present at Jefferies London Healthcare Conference
November 14, 2024
·
1 min read
Press Releases
Meiji Seika Pharma Announces Investment in ARCALIS, Inc.
November 14, 2024
·
3 min read
Press Releases
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
November 14, 2024
·
1 min read
1 of 68,557
Next
